|
Whole Model
|
Exp(b)
|
95% CI
|
P
|
|---|
|
Intercept
| | | |
|
Age (older)*
|
0.9907
|
0.9852 0.9962
|
0.0008
|
|
Gender
| | | |
|
Female
|
Reference
| |
0.2035
|
|
Male
|
1.0619
|
0.9684 1.1645
| |
|
Race
| | | |
|
Black
|
Reference
| |
<.0001
|
|
White*
|
0.7536
|
0.6880 0.8253
| |
|
Others*
|
0.7914
|
0.6265 0.9998
| |
|
HealthPlan
| | | |
|
uninsured
|
Reference
| |
<.0001
|
|
Medicaid*
|
1.2858
|
1.1165 1.4807
| |
|
Medicare*
|
1.1334
|
1.0041 1.2793
| |
|
Commercial*
|
1.6958
|
1.4796 1.9435
| |
|
CCI
|
1.0109
|
0.9724 1.0509
|
0.5863
|
|
A1c Lab normal*
|
0.8173
|
0.7444 0.8974
|
<.0001
|
|
Clinic adherence*
|
0.1585
|
0.1260 0.1994
|
<.0001
|
|
Duration in the prog.*
|
0.9684
|
0.9465 0.9907
|
0.0054
|
|
Prior hospitalization
|
1.0414
|
0.9485 1.1435
|
0.3945
|
|
Facility
| | | |
|
Smaller
|
Reference
| |
0.1180
|
|
Larger
|
0.9268
|
0.8427 1.0193
| |
- * is significant, P < 0.05
- CCI: Charlosn Comorbidity Index
- Note: Estimates from a GEE model that accounts for repeat visits by the same patient
